Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cosmo Technologies Ltd
Age
50–75
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Males or females, aged between 50 and 75.
Outpatients scheduled for screening or surveillance colonoscopy for polyps or colorectal cancer )
Able to comprehend the full nature and purpose of the study, including possible risks and side effects.
Able to co-operate with the investigator and to comply with the requirements of the entire study.
Signed written informed consent prior to inclusion in the study.
You may not be if
Patients at high risk of colorectal cancer e.g. ulcerative colitis
Previous medical history of, or suspected hypersensitivity to, the Methylene Blue and/or formulations' ingredients.
Previous medical history of, or suspected hypersensitivity to, the PEG based bowel cleansing preparation and/or bowel cleansing formulations' ingredients.
Previous medical history of gastrointestinal obstruction or perforation, toxic megacolon, major colonic resection, severe diverticulitis, heart failure (Class III or IV), serious cardiovascular disease, ulcerative colitis or Crohn's disease.
Clareo Health | The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
